137 related articles for article (PubMed ID: 6784743)
21. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
[TBL] [Abstract][Full Text] [Related]
22. Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system.
Bottai D; Frigui W; Clark S; Rayner E; Zelmer A; Andreu N; de Jonge MI; Bancroft GJ; Williams A; Brodin P; Brosch R
Vaccine; 2015 May; 33(23):2710-8. PubMed ID: 25869896
[TBL] [Abstract][Full Text] [Related]
23. [Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis].
Yamamoto T; Phalen S; Uchida K; Umemori K; Nojima Y; Horiuchi Y; Goto Y; McMurray DN; Yamamoto S
Kekkaku; 2000 May; 75(5):379-88. PubMed ID: 10853313
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs.
Sakthi S; Palaniyandi K; Gupta UD; Gupta P; Narayanan S
Vaccine; 2016 Feb; 34(6):735-43. PubMed ID: 26768127
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of protective effect of killed and live BCG bacilli and INH-resistant tubercle bacilli in guinea pigs].
Paklerska-Pobratyn H; Kostrzeński W
Gruzlica; 1968 Jun; 36(6):509-16. PubMed ID: 4970098
[No Abstract] [Full Text] [Related]
26. Infectivity and pathogenicity of drug-resistant strains of tubercle bacilli studied by aerogenic infection of guinea pigs.
Cohn ML; Davis CL
Am Rev Respir Dis; 1970 Jul; 102(1):97-100. PubMed ID: 4316799
[No Abstract] [Full Text] [Related]
27. Ultraviolet radiation reduces resistance to Mycobacterium tuberculosis infection in BCG-vaccinated guinea pigs.
Jeevan A; Sharma AK; McMurray DN
Tuberculosis (Edinb); 2009 Nov; 89(6):431-8. PubMed ID: 19850524
[TBL] [Abstract][Full Text] [Related]
28. Non-specific protection against pulmonary Legionella pneumophila infection in guinea-pigs immunized and challenged with mycobacteria.
Gibson DH; Baskerville A; Ashworth LA; Fitzgeorge RB
Br J Exp Pathol; 1985 Jun; 66(3):333-44. PubMed ID: 3924087
[TBL] [Abstract][Full Text] [Related]
29. Guinea-pig alveolar macrophage killing of Mycobacterium tuberculosis, in vitro, does not require hydrogen peroxide or hydroxyl radical.
O'Brien S; Andrew PW
Microb Pathog; 1991 Oct; 11(4):229-36. PubMed ID: 1667538
[TBL] [Abstract][Full Text] [Related]
30. VIRULENCE IN THE GUINEA-PIG AND SUSCEPTIBLITY TO HYDROGEN PEROXIDE OF ISONIAZID-SENSITIVE TUBERCLE BACILLI FROM SOUTH INDIAN PATIENTS.
NAIR CN; MACKAY-SCOLLAY EM; RAMACHANDRAN K; SELKON JB; TRIPATHY SP; MITCHISON DA; DICKINSON JM
Tubercle; 1964 Dec; 45():345-53. PubMed ID: 14239316
[No Abstract] [Full Text] [Related]
31. Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis.
Sander P; Clark S; Petrera A; Vilaplana C; Meuli M; Selchow P; Zelmer A; Mohanan D; Andreu N; Rayner E; Dal Molin M; Bancroft GJ; Johansen P; Cardona PJ; Williams A; Böttger EC
Vaccine; 2015 Mar; 33(11):1353-9. PubMed ID: 25657094
[TBL] [Abstract][Full Text] [Related]
32. THE IMMUNOGENICITY OF BCG (PHIPPS) AND ITS ISONIAZID-RESISTANT MUTANT IN GUINEA PIGS SIMULTANEOUSLY VACCINATED, INFECTED, AND TREATED.
DWORSKI M
Am Rev Respir Dis; 1964 Jul; 90():97-104. PubMed ID: 14180060
[No Abstract] [Full Text] [Related]
33. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
34. Vaccination with Bacille-Calmette Guérin promotes mycobacterial control in guinea pig macrophages infected in vivo.
Ly LH; Barhoumi R; Cho SH; Franzblau SG; McMurray DN
J Infect Dis; 2008 Sep; 198(5):768-71. PubMed ID: 18627245
[TBL] [Abstract][Full Text] [Related]
35. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
[TBL] [Abstract][Full Text] [Related]
36. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
[TBL] [Abstract][Full Text] [Related]
37. Role of lipid content and hydrogen peroxide susceptibility in determining the guinea-pig virulence of Mycobacterium tuberculosis.
Goren MB; Grange JM; Aber VR; Allen BW; Mitchison DA
Br J Exp Pathol; 1982 Dec; 63(6):693-700. PubMed ID: 6817780
[TBL] [Abstract][Full Text] [Related]
38. The attenuated W-115 strain of M. tuberculosis hominis and its isoniazid-resistant variant.
Weissfeiler J; Karasseva V
Am Rev Respir Dis; 1965 Dec; 92(6):870-6. PubMed ID: 4954268
[No Abstract] [Full Text] [Related]
39. Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. I. Experimental findings in guinea pigs.
Dworski M
Am Rev Respir Dis; 1973 Aug; 108(2):294-300. PubMed ID: 4578541
[No Abstract] [Full Text] [Related]
40. Lung macrophages from bacille Calmette-Guérin-vaccinated guinea pigs suppress T cell proliferation but restrict intracellular growth of M. tuberculosis after recombinant guinea pig interferon-gamma activation.
Jeevan A; Majorov K; Sawant K; Cho H; McMurray DN
Clin Exp Immunol; 2007 Aug; 149(2):387-98. PubMed ID: 17565610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
